Laboratory Medicine ›› 2018, Vol. 33 ›› Issue (2): 139-146.DOI: 10.3969/j.issn.1673-8640.2018.02.010
• Orginal Article • Previous Articles Next Articles
LI Huimin, MA Qingguang, LI Hongying
Received:
2017-04-25
Online:
2018-02-28
Published:
2018-03-02
CLC Number:
LI Huimin, MA Qingguang, LI Hongying. Role of pleural effusion interferon-gamma release assay for the diagnosis of tuberculous pleural effusion: a Meta analysis[J]. Laboratory Medicine, 2018, 33(2): 139-146.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2018.02.010
所纳入的研究 | 发表年 | 来源 | 年龄 | 性别 | 方法 | TP | FN或I | TN | FP | ||
---|---|---|---|---|---|---|---|---|---|---|---|
结核组 | 非结核组 | 结核组(男性,女性) | 非结核组(男性,女性) | ||||||||
(岁) | (岁) | ||||||||||
刘珍琼等[ | 2013 | 中国大陆 | 18~70 | 19~73 | 18,14 | 17,9 | T-SPOT.TB | 30 | 2 | 25 | 1 |
王美芳等[ | 2014 | 中国大陆 | 54.5±9.1 | 61.7±10.3 | 23,13 | 13,9 | T-SPOT.TB | 34 | 2 | 21 | 1 |
刘琳等[ | 2015 | 中国大陆 | 31±6 | 31±6 | 35,21 | 35,21 | T-SPOT.TB | 31 | 1 | 20 | 4 |
曹秀丽等[ | 2015 | 中国大陆 | 56.5±0.8 | 56.7±0.8 | 31,11 | 23,7 | T-SPOT.TB | 39 | 3 | 27 | 3 |
刘倩颖等[ | 2014 | 中国大陆 | 49.0±9.1 | 48.6±10.2 | 31,27 | 23,19 | T-SPOT.TB | 53 | 5 | 39 | 3 |
刘涛[ | 2015 | 中国大陆 | 50.0±9.4 | 54.2±12.6 | 29,13 | 27,15 | T-SPOT.TB | 40 | 2 | 38 | 4 |
朱敏等[ | 2015 | 中国大陆 | 42.1±17.3 | 45.8±15.6 | 26,12 | 20,14 | T-SPOT.TB | 36 | 2 | 31 | 3 |
庄妍等[ | 2015 | 中国大陆 | 47±15 | 48±18 | 18,14 | 19,12 | T-SPOT.TB | 30 | 2 | 28 | 3 |
石慧等[ | 2015 | 中国大陆 | 55(16~86) | 65(30~89) | 20,16 | 13,11 | T-SPOT.TB | 36 | 0 | 17 | 7 |
曹奇峰等[ | 2015 | 中国大陆 | 64(21~85) | 68(28~98) | 20,16 | 21,17 | T-SPOT.TB | 31 | 5 | 36 | 2 |
ZHANG等[ | 2014 | 中国大陆 | 54(34~69) | 未知 | 未知 | 未知 | T-SPOT.TB | 68 | 6 | 81 | 12 |
LIAO等[ | 2014 | 中国大陆 | 34.1±13.9 | 未知 | 82,199 | 未知 | T-SPOT.TB | 269 | 12 | 51 | 0 |
LIU等[ | 2013 | 中国大陆 | 39(25~59) | 57(47~67) | 18,37 | 18,25 | T-SPOT.TB | 52 | 3 | 39 | 2 |
ADILISTYA等[ | 2016 | 印度尼西亚 | 44.9±16.5 | 51.1±18.4 | 18,21 | 7,2 | T-SPOT.TB | 39 | 0 | 8 | 1 |
LIU等[ | 2014 | 中国大陆 | 39±19 | 57±15 | 41,18 | 29,23 | T-SPOT.TB | 54 | 5 | 47 | 5 |
KENG等[ | 2013 | 中国台湾 | 63.9±19.1 | 63.7±15.4 | 23,8 | 38,19 | T-SPOT.TB | 12 | 2(17) | 21 | 17 |
ELDIN等[ | 2012 | 埃及 | 48.0±14.7 | 48.0±14.7 | 26,12 | 26,12 | QFT-GIT | 12 | 8 | 15 | 3 |
KANG等[ | 2012 | 韩国 | 39.9±16.0 | 63.3±17.5 | 15,6 | 6,9 | T-SPOT.TB | 15 | 0(6) | 3 | 8 |
KANG等[ | 2012 | 韩国 | 39.9±16.0 | 63.3±17.5 | 15,6 | 6,9 | QFT-G | 4 | 0(17) | 7 | 6 |
LOSI等[ | 2007 | 意大利,德国,荷兰 | 32.0±16.0 | 71.5±15.0 | 10,8 | 22,8 | T-SPOT.TB | 19 | 1 | 16 | 5 |
ATES等[ | 2011 | 土耳其 | 32.9±20.7 | 53.3±19.4 | 47,25 | 47,25 | QFT-GIT | 21 | 4(8) | 23 | 3 |
所纳入的研究 | 发表年 | 来源 | 年龄 | 性别 | 方法 | TP | FN或I | TN | FP | ||
结核组 | 非结核组 | 结核组(男性,女性) | 非结核组(男性,女性) | ||||||||
(岁) | (岁) | ||||||||||
LOSI等[ | 2011 | 意大利 | 34(27~52) | 71(44~80) | 13,7 | 15,6 | QFT-GIT | 15 | 3 | 16 | 14 |
DHEDA等[ | 2009 | 南非 | 37.0±14.4 | 55.3±15.7 | 23,25 | 9,10 | QFT-GIT | 22 | 19(1) | 12 | 3 |
DHEDA等[ | 2009 | 南非 | 37.0±14.4 | 55.3±15.7 | 23,25 | 9,10 | T-SPOT.TB | 34 | 6(4) | 9 | 6 |
LEE等[ | 2009 | 中国台湾 | 60.5 | 65.5 | 15,4 | 12,9 | T-SPOT.TB | 18 | 1 | 18 | 3 |
BABA等[ | 2008 | 挪威 | 39(20~70) | 39(20~70) | 22,12 | 22,12 | QFT-GIT | 12 | 1(14) | 3 | 0 |
CHEGOU等[ | 2008 | 南非 | 35.0±13.0 | 未知 | 18,12 | 17,15 | QFT-GIT | 13 | 10 | 13 | 2 |
ARIGA等[ | 2007 | 日本 | 60.5±22.0 | 72.1±10.8 | 24,4 | 40,7 | QFT | 27 | 1 | 46 | 1 |
WILKINSON等[ | 2005 | 英国 | 32.0±2.8 | 65.0±5.0 | 4,6 | 3,5 | T-SPOT.TB | 10 | 0 | 7 | 1 |
所纳入的研究 | 发表年 | 来源 | 年龄 | 性别 | 方法 | TP | FN或I | TN | FP | ||
---|---|---|---|---|---|---|---|---|---|---|---|
结核组 | 非结核组 | 结核组(男性,女性) | 非结核组(男性,女性) | ||||||||
(岁) | (岁) | ||||||||||
刘珍琼等[ | 2013 | 中国大陆 | 18~70 | 19~73 | 18,14 | 17,9 | T-SPOT.TB | 30 | 2 | 25 | 1 |
王美芳等[ | 2014 | 中国大陆 | 54.5±9.1 | 61.7±10.3 | 23,13 | 13,9 | T-SPOT.TB | 34 | 2 | 21 | 1 |
刘琳等[ | 2015 | 中国大陆 | 31±6 | 31±6 | 35,21 | 35,21 | T-SPOT.TB | 31 | 1 | 20 | 4 |
曹秀丽等[ | 2015 | 中国大陆 | 56.5±0.8 | 56.7±0.8 | 31,11 | 23,7 | T-SPOT.TB | 39 | 3 | 27 | 3 |
刘倩颖等[ | 2014 | 中国大陆 | 49.0±9.1 | 48.6±10.2 | 31,27 | 23,19 | T-SPOT.TB | 53 | 5 | 39 | 3 |
刘涛[ | 2015 | 中国大陆 | 50.0±9.4 | 54.2±12.6 | 29,13 | 27,15 | T-SPOT.TB | 40 | 2 | 38 | 4 |
朱敏等[ | 2015 | 中国大陆 | 42.1±17.3 | 45.8±15.6 | 26,12 | 20,14 | T-SPOT.TB | 36 | 2 | 31 | 3 |
庄妍等[ | 2015 | 中国大陆 | 47±15 | 48±18 | 18,14 | 19,12 | T-SPOT.TB | 30 | 2 | 28 | 3 |
石慧等[ | 2015 | 中国大陆 | 55(16~86) | 65(30~89) | 20,16 | 13,11 | T-SPOT.TB | 36 | 0 | 17 | 7 |
曹奇峰等[ | 2015 | 中国大陆 | 64(21~85) | 68(28~98) | 20,16 | 21,17 | T-SPOT.TB | 31 | 5 | 36 | 2 |
ZHANG等[ | 2014 | 中国大陆 | 54(34~69) | 未知 | 未知 | 未知 | T-SPOT.TB | 68 | 6 | 81 | 12 |
LIAO等[ | 2014 | 中国大陆 | 34.1±13.9 | 未知 | 82,199 | 未知 | T-SPOT.TB | 269 | 12 | 51 | 0 |
LIU等[ | 2013 | 中国大陆 | 39(25~59) | 57(47~67) | 18,37 | 18,25 | T-SPOT.TB | 52 | 3 | 39 | 2 |
ADILISTYA等[ | 2016 | 印度尼西亚 | 44.9±16.5 | 51.1±18.4 | 18,21 | 7,2 | T-SPOT.TB | 39 | 0 | 8 | 1 |
LIU等[ | 2014 | 中国大陆 | 39±19 | 57±15 | 41,18 | 29,23 | T-SPOT.TB | 54 | 5 | 47 | 5 |
KENG等[ | 2013 | 中国台湾 | 63.9±19.1 | 63.7±15.4 | 23,8 | 38,19 | T-SPOT.TB | 12 | 2(17) | 21 | 17 |
ELDIN等[ | 2012 | 埃及 | 48.0±14.7 | 48.0±14.7 | 26,12 | 26,12 | QFT-GIT | 12 | 8 | 15 | 3 |
KANG等[ | 2012 | 韩国 | 39.9±16.0 | 63.3±17.5 | 15,6 | 6,9 | T-SPOT.TB | 15 | 0(6) | 3 | 8 |
KANG等[ | 2012 | 韩国 | 39.9±16.0 | 63.3±17.5 | 15,6 | 6,9 | QFT-G | 4 | 0(17) | 7 | 6 |
LOSI等[ | 2007 | 意大利,德国,荷兰 | 32.0±16.0 | 71.5±15.0 | 10,8 | 22,8 | T-SPOT.TB | 19 | 1 | 16 | 5 |
ATES等[ | 2011 | 土耳其 | 32.9±20.7 | 53.3±19.4 | 47,25 | 47,25 | QFT-GIT | 21 | 4(8) | 23 | 3 |
所纳入的研究 | 发表年 | 来源 | 年龄 | 性别 | 方法 | TP | FN或I | TN | FP | ||
结核组 | 非结核组 | 结核组(男性,女性) | 非结核组(男性,女性) | ||||||||
(岁) | (岁) | ||||||||||
LOSI等[ | 2011 | 意大利 | 34(27~52) | 71(44~80) | 13,7 | 15,6 | QFT-GIT | 15 | 3 | 16 | 14 |
DHEDA等[ | 2009 | 南非 | 37.0±14.4 | 55.3±15.7 | 23,25 | 9,10 | QFT-GIT | 22 | 19(1) | 12 | 3 |
DHEDA等[ | 2009 | 南非 | 37.0±14.4 | 55.3±15.7 | 23,25 | 9,10 | T-SPOT.TB | 34 | 6(4) | 9 | 6 |
LEE等[ | 2009 | 中国台湾 | 60.5 | 65.5 | 15,4 | 12,9 | T-SPOT.TB | 18 | 1 | 18 | 3 |
BABA等[ | 2008 | 挪威 | 39(20~70) | 39(20~70) | 22,12 | 22,12 | QFT-GIT | 12 | 1(14) | 3 | 0 |
CHEGOU等[ | 2008 | 南非 | 35.0±13.0 | 未知 | 18,12 | 17,15 | QFT-GIT | 13 | 10 | 13 | 2 |
ARIGA等[ | 2007 | 日本 | 60.5±22.0 | 72.1±10.8 | 24,4 | 40,7 | QFT | 27 | 1 | 46 | 1 |
WILKINSON等[ | 2005 | 英国 | 32.0±2.8 | 65.0±5.0 | 4,6 | 3,5 | T-SPOT.TB | 10 | 0 | 7 | 1 |
[1] | 刘珍琼,段永和,张齐龙,等. T-SPOT.TB技术检测胸腔积液在结核性胸膜炎诊断中的应用[J]. 实验与检验医学,2013,31(4):306-308. |
[2] | 王美芳,顾翔月. T-SPOT.TB实验在结核性胸腔积液中的诊断价值[J]. 中华全科医学,2014,12(8):1356-1357. |
[3] | 刘琳,胡克. 胸腔积液结核感染T细胞斑点试验在结核性胸腔积液中的诊断价值[J]. 医学综述,2015,21(2):324-326. |
[4] | 曹秀丽,王兰. 胸腔积液结核感染T细胞斑点实验检测对结核性胸膜炎的辅助诊断价值[J]. 中国煤炭工业医学杂志,2015,19(7):1094-1097. |
[5] | 刘倩颖,王心静,林明贵. 结核感染T细胞斑点试验在结核性胸腔积液诊断中的意义[J]. 解放军医药杂志,2014,26(8):89-91. |
[6] | 刘涛. T-SPOT.TB技术在结核性胸膜炎诊断中的意义[J]. 国际检验医学杂志,2015,36(9):1283-1284. |
[7] | 朱敏,李英,马希涛. 结核杆菌感染T细胞斑点试验和腺苷脱氨酶检测对结核性胸膜炎诊断价值探讨[J]. 河南医学高等专科学校学报,2015,28(5):575-578. |
[8] | 庄妍,赖雁平. 结核T 细胞斑点试验在结核性胸膜炎中的价值[J]. 天津医科大学学报,2015,21(4):335-338. |
[9] | 石慧,崔丽英. 结核感染T细胞斑点试验诊断结核性胸膜炎的应用价值[J]. 中华肺部疾病杂志(电子版),2015,8(2):51-54. |
[10] | 曹奇峰,杨卫琴,瞿美君. 外周血联合胸腔积液应用T SPOT-TB 检测对于诊断结核性胸膜炎的临床研究[J]. 现代实用医学,2015,27(12):1588-1590. |
[11] | AGGARWAL A N,AGARWAL R,GUPTA D,et al.Interferon gamma release assays for diagnosis of pleural tuberculosis:a systematic review and meta-analysis[J]. J Clin Microbiol,2015,53(8):2451-2459. |
[12] | ZHOU Q,CHEN Y Q,QIN S M,et al.Diagnostic accuracy of T-cell interferon-γ release assays in tuberculous pleurisy:a meta-analysis[J]. Respirology,2011,16(3):473-480. |
[13] | 邬兰,张永,曾献涛. QUADAS-2在诊断准确性研究的质量评价工具中的应用[J]. 湖北医药学院学报,2013,32(3):201-208. |
[14] | ZHANG L,ZHANG Y,SHI X,et al.Utility of T-cell interferon-γ release assays for diagnosing tuberculous serositis:a prospective study in Beijing,China[J]. PLoS One,2014,9(1):e85030. |
[15] | LIAO M,YANG Q,ZHANG J,et al.Gamma interferon immunospot assay of pleural effusion mononuclear cells for diagnosis of tuberculous pleurisy[J]. Clin Vaccine Immunol,2014,21(3):347-353. |
[16] | LIU F,GAO M,ZHANG X,et al.Interferon-gamma release assay performance of pleural fluid and peripheral blood in pleural tuberculosis[J]. PLoS One,2013,8(12):e83857. |
[17] | ADILISTYA T,ASTRAWINATA D A,NASIR U Z.Use of pleural fluid interferon-gamma enzyme-linked immunospot assay in the diagnosis of pleural tuberculosis[J]. Acta Med Indones,2016,48(1):41-47. |
[18] | 刘菲,张霞,杜凤娇,等. γ-干扰素释放试验检测胸腔积液对诊断结核性胸膜炎的初步探讨[J]. 中华结核和呼吸杂志,2014,37(5):323-327. |
[19] | KENG L T,SHU C C,CHEN J Y,et al.Evaluating pleural ADA,ADA2,IFN-γ and IGRA for diagnosing tuberculous pleurisy[J]. J Infect,2013,67(4):294-302. |
[20] | ELDIN E N,OMAR A,KHAIRY M,et al.Diagnostic value of ex vivo pleural fluid interferon-gamma versus adapted whole-blood quantiferon-TB gold in tube assays in tuberculous pleural effusion[J]. Ann Thorac Med,2012,7(4):220-225. |
[21] | KANG J Y,RHEE C K,KANG N H,et al.Clinical utility of two interferon-gamma release assays on pleural fluid for the diagnosis of tuberculous pleurisy[J]. Tuberc Respir Dis(Seoul),2012,73(3):143-150. |
[22] | LOSI M,BOSSINK A,CODECASA L,et al.Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy[J]. Eur Respir J,2007,30(6):1173-1179. |
[23] | ATES G,YILDIZ T,ORTAKOYLU M G,et al.Adapted T cell interferon-gamma release assay for the diagnosis of pleural tuberculosis[J]. Respiration,2011,82(4):351-357. |
[24] | LOSI M,BOCCHINO M,MATARESE A,et al.Role of the quantiferon-TB test in ruling out pleural tuberculosis:a multi-centre study[J]. Int J Immunopathol Pharmacol,2011,24(1):159-165. |
[25] | DHEDA K,VAN ZYL-SMIT R N,SECHI L A,et al. Utility of quantitative T-cell responses versus unstimulated interferon-gamma for the diagnosis of pleural tuberculosis[J]. Eur Respir J,2009,34(5):1118-1126. |
[26] | LEE L N,CHOU C H,WANG J Y,et al.Enzyme-linked immunospot assay for interferon-gamma in the diagnosis of tuberculous pleurisy[J]. Clin Microbiol Infect,2009,5(2):173-179. |
[27] | BABA K,SØRNES S,HOOSEN A A,et al. Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON TB-Gold interferon-gamma assay[J]. BMC Infect Dis,2008,8:35. |
[28] | CHEGOU N N,WALZL G,BOLLIGER C T,et al.Evaluation of adapted whole-blood interferon-gamma release assays for the diagnosis of pleural tuberculosis[J]. Respiration,2008,76(2):131-138. |
[29] | ARIGA H,KAWABE Y,NAGAI H,et al.Diagnosis of active tuberculous serositis by antigen-specific interferon-gamma response of cavity fluid cells[J]. Clin Infect Dis,2007,45(12):1559-1567. |
[30] | WILKINSON K A,WILKINSON R J,PATHAN A,et al.Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis[J]. Clin Infect Dis,2005,40(1):184-187. |
[31] | 高孟秋. γ-干扰素释放试验检测结果的临床意义解读[J]. 中华结合和呼吸杂志,2014,37(10):742-743. |
[32] | LI Z Z,QIN W Z,LI L,et al.Accuracy of enzyme-linked immunospot assay for diagnosis of pleural tuberculosis:a meta-analysis[J]. Genet Mol Res,2015,14(3):11672-11680. |
[1] | SUN Xinlin, YE Xingming, LI Qian, ZHAO Lijun. Bronchoscopy combined with sputum Mycobacterium tuberculosis ribonucleic acid and serum Mycobacterium tuberculosis specific antibody determinations for diagnosis of negative pulmonary tuberculosis [J]. Laboratory Medicine, 2023, 38(9): 870-873. |
[2] | MIAO Xingguo, YE Hui, SU Feifei. Relationship between GeneXpert MTB/RIF assay determination load and Mycobacterium tuberculosis culture and phenotype of rifampicin resistance [J]. Laboratory Medicine, 2023, 38(9): 874-877. |
[3] | YANG Liyuan, DAI Wanqin, WANG Xiaotong, LOU Xiaoli, WANG Yue, HOU Yanqiang. Effect of peripheral blood neutrophils on interferon-gamma release assay of Mycobacterium tuberculosis [J]. Laboratory Medicine, 2023, 38(5): 484-488. |
[4] | GAI Linlin, LI Haibo, CHU Jinjin, SUN Jiamei, YAN Xinyi, DU Jinke, DAI Wenqing, XU Donghua. Role of chemiluminescence interferon gamma release assay in auxiliary diagnosis of pulmonary tuberculosis [J]. Laboratory Medicine, 2023, 38(3): 257-260. |
[5] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[6] | RU Haohao, CHEN Lianyong, YANG Xing, CHEN Tao, YAN Shuangqun, XU Lin. Analysis of rifampicin resistance in Mycobacterium tuberculosis determined by Xpert MTB/RIF and phenotypic drug susceptibility test [J]. Laboratory Medicine, 2023, 38(11): 1032-1035. |
[7] | XU Liuyue, LIAO Qinghua, PENG Kehao, YU Meiling, CHEN Yanmei, ZHUO Wenji, LAI Xiaoyu. Application of nucleic acid aptamer fluorescence probe method and liquid-based sandwich cup method in the determination of Mycobacterium tuberculosis [J]. Laboratory Medicine, 2023, 38(10): 915-918. |
[8] | DU Jinghui, HUANG Zikun, LIU Min, GONG Jingjing, WANG Dan, LIU Jibo, LIU Xu. Rapid determination of minimum inhibitory concentration and cut-off concentration of Mycobacterium tuberculosis by nitrate reductase assay using liquid medium [J]. Laboratory Medicine, 2022, 37(6): 568-576. |
[9] | LI Hua, WANG Weiliang, XIE Bei, YANG Yu, MENG Fanrong, WANG Nan, LIU Zhihui, ZHANG Yanbin. Feasibility of the determination of heterogeneous drug resistance to rifampicin in Mycobacterium tuberculosis by flow cytometry [J]. Laboratory Medicine, 2022, 37(6): 577-582. |
[10] | LI Xiaoqian, WANG Zhihui, CHI Yuepeng, WANG Yuhong, XIE Lanpin, LIANG Yachong. Analysis of diagnostic efficacy of serum MMP-9 with or without Xpert MTB/RIF assay in alveolar lavage fluid and INF-γ release test for pulmonary tuberculosis [J]. Laboratory Medicine, 2022, 37(1): 11-15. |
[11] | ZHANG Guoying, HE Fang, XIA Xia, GUO Yidi, XU Weiping, HUANG Zihui. Diagnosis value of Xpert MTB/RIF assay for different types of lymph node tuberculosis [J]. Laboratory Medicine, 2021, 36(9): 935-938. |
[12] | ZHAO Ying, Gasongzhuoga, Cibai, LIU Zhijuan, XU Yingchun. Application of Xpert MTB/RIF in tuberculosis diagnosis in high altitude localities [J]. Laboratory Medicine, 2021, 36(9): 947-950. |
[13] | LI Dian, ZHENG Zheng, JIANG Yezhou. Roles of serum GM-CSF,sTREM-1 combined with T-SPOT.TB in the differential diagnosis of pulmonary tuberculosis [J]. Laboratory Medicine, 2021, 36(8): 833-836. |
[14] | YU Chenlei, JIANG Yuan, LI Jing, WANG Lili, CHEN Wei, SHEN Xuhui, ZHANG Yangyi. Application of BAC spreader for minimum inhibitory concentration determination in Mycobacterium tuberculosis [J]. Laboratory Medicine, 2021, 36(6): 650-655. |
[15] | LIN Xiaoling, LIANG Lifeng, WU Yingtao, ZHAO Jieming, CAI Qiuyue. An drug resistance analysis on the mycobacterium tuberculosis complex of pulmonary tuberulosis in Yunfu city [J]. Laboratory Medicine, 2021, 36(2): 194-197. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||